Pediatric Neurosurgery XR Solutions Market : Global Industry Analysis and Opportunity Assessment, 2036

How big is Pediatric Neurosurgery XR Solutions Market in 2026?

USD 1,179.2 million in 2026 and USD 3,229.6 million by 2036 at a 10.6% CAGR.

Demand for pediatric neurosurgery XR solutions is projected to expand at 10.6% CAGR from 2026 to 2036, supported by multidisciplinary planning and navigation requirements. Industry valuation is forecast to rise from USD 1,179.2 million in 2026 to USD 3,229.6 million by 2036, reflecting broader use across planning and communication workflows. Pediatric hospitals justify spending through interactive three-dimensional imaging that changes a named planning decision or reduces interpretation differences across multidisciplinary reviews. Stanford Medicine Children's Health describes Surgical Theater as a three-dimensional virtual-reality platform used for planning and family education in pediatric neurosurgery. Hospitals therefore compare surgical navigation systems with planning software and headset hardware through separate clinical acceptance tests. Commercial conversion depends on validated image fidelity plus specialist training and service support that remains available throughout complex pediatric cases. A purchase becomes defensible once the implementation plan assigns registration checks and data ownership plus fallback procedures to named hospital teams.

United States procurement follows FDA clearance and hospital capital review, while Japanese adoption often enters through certified software and institution-led evaluation. British hospitals emphasize multidisciplinary case discussion inside publicly commissioned services whereas German institutions also test interoperability with national digital records. South Korean tertiary centers combine pediatric surgery reimbursement changes with domestic development across augmented-reality surgical tools. The FDA medical-device list current in June 2026 includes recent authorizations for Medivis and Brainlab across radiology or neurology panels. The same list also includes Surgical Theater and Avatar Medical among systems used for visualization or surgical guidance. Purchasing teams must separate cranial navigation platforms from visualization tools because regulatory clearance does not establish pediatric workflow suitability. Market entry therefore requires local service coverage plus training and cybersecurity support throughout a long hospital procurement cycle.

Summary of the Pediatric Neurosurgery XR Solutions Market

Market Signal	Commercial Impact
Demand and Growth Drivers	Complex pediatric anatomy creates spending pressure whenever conventional images leave important spatial relationships open to different clinical interpretations. Patient-specific three-dimensional views support joint planning across neurosurgery and radiology teams that must agree on one operative route. Reusable planning sessions can reduce repeated image explanation while preserving an auditable reference for complex case conferences. Training value strengthens the purchasing case when one platform supports attending surgeons and fellows across several pediatric procedures. Service reliability becomes a demand condition because headset failure or registration drift can interrupt high-consequence clinical workflows.
Product and Segment View	The product stack combines physical display equipment with software and clinical services that convert patient imaging into usable spatial guidance. Hardware is estimated to hold 40.1% share in 2026 due to headsets and computing equipment plus protected clinical accessories. Preoperative planning is projected to represent 33.4% share in 2026 owing to repeated use before complex pediatric procedures. Virtual reality is forecast to account for 33.0% share in 2026 because immersive review separates planning from the operating field. Pediatric hospitals are anticipated to capture 30.4% share in 2026 through concentrated specialists and formal technology governance.
Geography and Growth Outlook	Country growth differs through reimbursement and regulatory routes plus the availability of specialist hospitals that can maintain XR workflows. South Korea is forecast at 13.0% CAGR by 2036 within the profiled comparison, driven by broader pediatric surgery reimbursement. The UK is projected at 12.2% CAGR through 2036 as specialist networks evaluate collaborative planning inside public care pathways. Japan is estimated at 11.9% CAGR over the assessment period, supported by certified domestic software and institution-led technology assessment. Germany records 9.5% CAGR from 2026 to 2036 while interoperability and reimbursement conditions create a more measured adoption route.
Competitive Landscape	Competition separates planning platforms from registered navigation systems and education tools with different responsibilities during pediatric care. Brainlab and Surgical Theater support patient-specific planning through interactive three-dimensional anatomy and workflow-oriented clinical visualization. Medivis and Novarad connect spatial imaging with navigation functions that require registration discipline plus documented use boundaries. ImmersiveTouch and Avatar Medical emphasize planning communication across surgeons and patients through device-flexible three-dimensional review. Holoeyes and apoQlar provide certified visualization platforms that combine surgical planning with training or collaborative clinical review.
Analyst Perspective	The commercial decision rests on whether one XR workflow improves a documented clinical decision without adding unmanaged technical responsibility. Hospital committees should test registration accuracy and image preparation time separately because both measures change daily clinical value. Pediatric teams need role-based training that covers surgeons and imaging specialists plus biomedical engineering and information-security staff. Contracts should identify headset replacement and software support terms alongside the clinical owner responsible for exceptions. - Anurag Sharma, Principal Analyst at Future Market Insights

Source: FMI's proprietary forecasting model and primary research

How is the pediatric neurosurgery XR solutions market segmented?

The pediatric neurosurgery XR solutions market is segmented by component, application, technology, end user, and region.

Component analysis separates hardware from software and services plus platforms that deliver a complete XR workflow. Application categories distinguish preoperative planning from surgical navigation and professional training plus patient education across the care pathway. Technology separates virtual reality from augmented reality and mixed reality plus broader extended reality systems. End-user analysis distinguishes pediatric hospitals from neurosurgery centers and academic medical centers plus specialty clinics. Regional coverage compares adoption through national regulation and care delivery plus specialist service availability across different hospital systems.

How does hardware influence pediatric XR deployment within the Component category?

Hardware determines whether patient-specific anatomy can be viewed with sufficient depth and stable interaction during clinical review. Headsets and computing equipment also require cleaning protocols plus device management and protected access to hospital imaging systems. Brainlab states that its Mixed Reality Viewer works with Brainlab Elements and Magic Leap 2 for patient-specific neurosurgical planning. Hospitals comparing augmented reality hardware must therefore test ergonomics and image stability alongside compatibility with local security controls.

• By component, hardware is estimated to hold 40.1% share in 2026, attributable to stereoscopic viewing equipment and reliable image-interaction requirements. The position also reflects replacement exposure and accessories plus computing resources that software subscriptions cannot eliminate.
• Biomedical engineering teams favor modular hardware that supports controlled replacement without forcing a complete platform migration. Pediatric programs gain operational value through headsets that fit different clinicians and remain serviceable between scheduled procedures. Device standardization also reduces setup variation across operating rooms and planning spaces during routine pediatric case preparation.

What supports demand for preoperative planning within the Application category?

Preoperative planning helps pediatric teams examine narrow corridors and changing anatomy before entering a high-consequence surgical environment. Patient-specific models can support rehearsal and multidisciplinary discussion while leaving final clinical judgment with the operating surgeon. Planning systems also preserve a shared visual reference for neuroradiology and anesthesia plus family communication. Commercial comparison with medical imaging software depends on preparation time and segmentation quality plus access across approved devices.

• Preoperative planning is projected to account for 33.4% share of application in 2026, driven by repeated use across case preparation and team review. Avatar Medical announced CE marking in March 2025 for software supporting three-dimensional review and virtual-reality surgical planning.
• Pediatric neurosurgeons select planning tools that reveal lesion relationships without requiring a headset throughout every clinical conversation. Adoption strengthens when models can be revisited during consent and teaching plus final operative preparation. Reusable access also supports repeated case review without rebuilding the complete patient model for each multidisciplinary meeting cycle.

How do pediatric neurosurgery teams evaluate virtual reality within the Technology category?

Virtual reality creates an immersive planning space that removes surrounding visual distractions and supports close inspection of complex anatomy. The technology fits scheduled review sessions more naturally than continuous intraoperative guidance because clinicians enter a separate visual environment. Clinical teams can compare immersive depth against headset tolerance and the time required to prepare each model. Hospital evaluations should compare extended reality systems through model preparation and clinician comfort plus repeatability across different headsets.

• Virtual reality is forecast to represent 33.0% share of technology in 2026, supported by its established role in immersive planning and simulation. The category can deliver detailed spatial review without requiring patient registration inside the operating room. Planning-focused virtual reality deployments reduce implementation burden by remaining outside registered intraoperative guidance workflows during initial hospital evaluations.
• Academic neurosurgery programs use virtual reality for case rehearsal and resident teaching across uncommon pediatric anatomy. ImmersiveTouch presents ImmersiveView as an FDA-cleared planning platform for cranial and craniofacial procedures using patient-specific anatomy. Routine use depends on a simple launch process and reusable content plus clear limits between education and clinical decision support.

What makes pediatric hospitals central to the End User category?

Pediatric hospitals concentrate neurosurgeons and neuroradiologists plus specialized anesthesia teams around complex cases that benefit from shared spatial review. Their technology committees can also assign clinical and technical ownership across planning and operating environments. King's College Hospital reported in December 2025 that its pediatric neuro-oncology network was assessed across 168 points and commended for imaging training. Institutions comparing mixed reality surgery must connect technology evaluation with established quality programs rather than isolated demonstrations.

• Pediatric hospitals are anticipated to capture 30.4% share in 2026, owing to concentrated specialist teams and formal technology governance. Their procedure mix can support repeated planning use across tumors and vascular conditions plus craniofacial cases. Concentrated imaging expertise can also reduce patient-model preparation delays across tightly scheduled pediatric surgical planning sessions.
• Hospital digital committees adopt XR platforms through staged reviews that include clinicians and biomedical engineers plus information-security specialists. A scalable program requires training coverage and documented device support alongside measurable use across more than one surgical service. Hospital governance must assign responsibility for technical exceptions and replacement equipment throughout routine clinical service operations.

What are the drivers, restraints, and opportunities in the pediatric neurosurgery XR solutions market?

Complex pediatric anatomy supports demand for spatial planning; accuracy and cybersecurity requirements restrain routine deployment; collaborative platforms create a practical service opportunity.

• Driver: Multidisciplinary teams need one patient-specific spatial reference that reduces interpretation differences before complex pediatric procedures.
• Restraint: Hospitals cannot expand XR use without validated registration and cybersecurity controls plus dependable technical support.
• Opportunity: Device-flexible collaboration can extend specialist case review and training across hospitals without transferring operative responsibility.

Demand increases through pediatric cases that require several specialists to interpret anatomy and agree on a safe surgical corridor. XR planning can place tumor margins and vessels plus cranial structures inside one interactive view before the operative schedule begins. An August 2025 Journal of Neurosurgery: Pediatrics study documented augmented-reality guidance during pediatric craniofacial procedures performed through a multidisciplinary clinical workflow. Hospitals assessing holographic medical imaging therefore need evidence that spatial review changes a named decision rather than providing another display.

Routine deployment faces a prominent constraint through image-registration risk and connected-device exposure inside protected hospital networks. A technically impressive model has limited clinical value if the headset drifts or patient data cannot enter the approved cybersecurity process. Hospitals comparing mixed reality navigation must also maintain a fallback workflow that preserves care during software or hardware interruptions. FDA guidance issued in February 2026 recommends cybersecurity design and documentation for devices carrying cyber risk during premarket review.

Remote specialist review creates a credible opportunity for platforms that share patient-specific anatomy across controlled clinical teams. Avatar Medical announced in June 2026 that UHealth had begun deploying glasses-free three-dimensional visualization within neurological surgery consultations. The use case supports medical holography for education and collaborative planning without presenting remote discussion as proof of commercial adoption. Technology providers must package secure access and headset training plus local clinical ownership to convert collaboration into repeatable service.

Which country CAGRs are profiled in the pediatric neurosurgery XR solutions market?

Country	CAGR
USA	11.4%
UK	12.2%
Germany	9.5%
Japan	11.9%
South Korea	13.0%

How do country-level CAGRs compare in the pediatric neurosurgery XR solutions market?

The profiled CAGRs span 3.6 percentage points and show several distinct adoption routes rather than one uniform national pattern. The UK and Japan form a close pair separated by 0.4 percentage point through public specialist pathways and domestic software evaluation. The USA sits 0.4 percentage point below Japan and follows a clearance-led procurement route with strong hospital capital review. South Korea stands 0.8 percentage point above the UK through reimbursement support and concentrated tertiary infrastructure. Germany remains 2.0 percentage points below the USA because interoperability and payment requirements create a more measured commercial route.

• South Korea outlook is reinforced by broader reimbursement and concentrated technology development across tertiary centers.
• The UK is supported by nationally commissioned specialist services and focused collaborative planning evaluation.
• Expansion in Japan is linked to certified domestic visualization software and structured institutional purchasing.
• The USA demand outlook is shaped by regulated clearance and hospital investment processes requiring service responsibility.
• Germany is predicted to grow, influenced by digital integration requirements across hospitals and contracted technology providers.

Similar rates can produce different entry conditions because service distance and training capacity affect whether approved systems operate reliably. Financing and cybersecurity review also change project timing even across countries with comparable specialist demand.The full report provides country-level CAGR analysis across North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East and Africa.

Country-wise Analysis

• United States children's hospitals combine specialist neurosurgery programs with formal capital review and device cybersecurity governance. The United States pediatric neurosurgery XR solutions market is projected to grow at 11.4% CAGR through 2036, supported by clearance-led purchasing. Avatar Medical announced FDA clearance in April 2026 for software processing CT and MR data across screens and virtual-reality environments. Regulated availability provides a direct enabler for planning adoption while pediatric validation remains a material local friction. Hospital contracts need training and service terms plus a documented fallback process for procedures that cannot tolerate interrupted visualization.
• United Kingdom pediatric neuroscience services operate through nationally commissioned pathways that concentrate complex cases within specialist hospitals. Demand for pediatric neurosurgery XR solutions in the UK is forecast to rise at 12.2% CAGR during the forecast period, shaped by public clinical evaluation. Imperial College Healthcare NHS Trust reported a remote mixed-reality neurosurgical case discussion with a United States team in February 2025. Concentrated expertise enables collaborative planning while public procurement evidence requirements can slow wider purchasing across regional contracts. Providers need secure deployment and structured training plus service support that fits NHS information-governance responsibilities.
• German hospitals purchase digital surgical tools inside an environment that increasingly requires interoperability with national health infrastructure. Germany's pediatric neurosurgery XR solutions market is estimated to post 9.5% CAGR from 2026 to 2036, influenced by integration discipline. The Federal Ministry of Health stated in December 2025 that nonconforming ePA software systems could no longer support billable services from January 2026. The digital infrastructure creates an adoption enabler while integration testing and reimbursement alignment remain material local frictions. Manufacturers need German-language support and documented compatibility plus regional maintenance coverage for long hospital evaluation cycles.
• Japanese hospitals can evaluate domestic certified visualization software through institutional purchasing routes that emphasize documented clinical use. Adoption of pediatric neurosurgery XR solutions in Japan is anticipated to expand at 11.9% CAGR over the assessment period, enabled by local product certification. Holoeyes reported in April 2026 that Tokyo recognized Holoeyes MD under its trial procurement program for innovative products. The program provides a purchasing enabler while reimbursement scope and specialist training remain practical local frictions. Technology providers need dependable DICOM preparation and domestic service support plus clear device requirements across participating hospitals.
• South Korean tertiary hospitals combine dense digital infrastructure with specialist pediatric surgery programs and active domestic XR development. The South Korea pediatric neurosurgery XR solutions market is predicted to advance at 13.0% CAGR by 2036, reinforced by improved pediatric surgery reimbursement. The Ministry of Health and Welfare added 319 complex surgery items for children under six in February 2025 and created a 100% add-on across 487 procedures for older children. Expanded payment provides a direct enabler while tertiary concentration and limited specialist training remain material frictions outside major centers. Commercial entry requires local clinical education and maintenance coverage plus evidence that XR improves one reimbursed surgical workflow.

Who are the notable companies in the pediatric neurosurgery XR solutions market?

Brainlab; Surgical Theater; Medivis; ImmersiveTouch; Holoeyes; apoQlar; Avatar Medical; and Novarad are the notable companies shaping this market.

The competitive structure separates patient-specific planning platforms from registered navigation systems and communication tools with different clinical responsibilities. Brainlab and Medivis connect spatial imaging with surgical guidance while Surgical Theater emphasizes planning and immersive case review. ImmersiveTouch and Avatar Medical support shared three-dimensional interpretation across clinical consultations and structured patient communication sessions. Holoeyes and apoQlar provide certified software for planning and education across several device environments used by multidisciplinary teams. Novarad links patient-specific planning with augmented-reality navigation and documented pediatric craniofacial use across selected clinical sites. Hospitals comparing minimally invasive neurosurgery devices need evidence for the named procedure plus local training and service coverage rather than corporate scale.

• Brainlab and Surgical Theater offer patient-specific three-dimensional planning that supports multidisciplinary review and preparation for complex neurosurgical procedures.
• Medivis and Novarad provide augmented-reality navigation functions that require verified registration workflows and clear operating responsibility inside the hospital.
• ImmersiveTouch and Avatar Medical plus Holoeyes and apoQlar emphasize planning communication and education across different certified visualization environments.

Competitive Benchmarking: Pediatric Neurosurgery XR Solutions Market

Company	Pediatric Planning Fit	XR Navigation	Training and Communication	Geographic Reach
Brainlab	High	High	Medium	Global
Surgical Theater	High	High	High	North America and selected global hospitals
Medivis	High	High	Medium	United States and selected markets
ImmersiveTouch	High	Medium	High	North America
Holoeyes	High	Medium	High	Japan and selected Asian markets
apoQlar	High	Medium	High	Europe and selected international markets
Avatar Medical	High	Medium	High	United States and Europe
Novarad	Medium	High	Medium	North America and selected markets

Scoring basis: High pediatric planning fit requires dedicated patient-specific neurosurgical visualization with documented clinical use or regulatory clearance. Medium planning fit covers direct surgical planning with limited pediatric workflow depth, and Low requires documented absence of dedicated patient-specific planning functions. High XR navigation requires registered instrument guidance or patient-aligned overlays with documented procedural use across surgical workflows. Medium navigation covers procedural visualization without full guidance control, and Low requires documented support limited to non-navigated viewing. High training and communication requires dedicated teaching functions plus consent or multidisciplinary review supported through official product evidence. Medium indicates secondary support inside a clinical platform, and Low requires documented capability limited to specialist visualization without shared-learning functions. Missing evidence never receives a Low rating because companies lacking sufficient official support for every capability cell are excluded from comparison.

Key Developments in the Pediatric Neurosurgery XR Solutions Market

• In December 2025, Medivis received FDA 510(k) clearance for its Cranial Navigation platform and described the system as augmented-reality guidance for cranial neurosurgery. The clearance expands the commercial comparison from planning visualization toward registered intraoperative guidance and gives hospitals another portable option for procedures requiring direct spatial alignment. Procurement reviews can now compare registration controls and support requirements against established cranial navigation systems.
• In September 2025, Brainlab announced FDA clearance and a United States launch for Spine Mixed Reality Navigation. The system combines optical navigation with mixed-reality visualization inside the surgeon's field of view and strengthens Brainlab's current navigation evidence across minimally invasive procedures. Hospital review must separate the cleared spine use from pediatric cranial suitability during procedure-specific governance and training.
• In January 2026, Holoeyes released Holoeyes MD version 3.2 with a Library function and expanded Navi view support across Meta Quest and Apple Vision Pro. The update broadens device choice and enables approved users to review consented reference models alongside patient-specific content for planning or education. Broader headset support can reduce replacement exposure across institutions using different approved computing environments and procurement standards.
• In May 2025, Novarad documented a VisAR-guided spinal procedure in Mallorca that used combined silhouette and X-ray registration without a navigation tower inside the operating room. The deployment illustrates a lower-footprint route for augmented-reality guidance while leaving pediatric cranial use dependent on procedure-specific evidence and regulatory scope. Hospitals can test portable workflow economics without treating one adult spine deployment as pediatric adoption proof.

Key Players in the Pediatric Neurosurgery XR Solutions Market

XR Planning and Navigation Providers

• Brainlab
• Surgical Theater
• Medivis
• Novarad

Immersive Planning and Education Platforms

• ImmersiveTouch
• Avatar Medical

Medical Visualization Platform Providers

• Holoeyes
• apoQlar

Pediatric Neurosurgery XR Solutions Market - Report Scope

Coverage field	Report scope
Market breakdown	Component, application, technology, end user, and region.
Quantitative Units	USD million
Market Definition	Hardware, software, services, and platforms used to visualize patient-specific anatomy for pediatric neurosurgical planning, navigation, training, or patient education.
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
Countries Covered	USA, UK, Germany, Japan, and South Korea.
Key Companies Profiled	Brainlab, Surgical Theater, Medivis, ImmersiveTouch, Holoeyes, apoQlar, Avatar Medical, and Novarad.
Forecast Period	2026 to 2036.
Approach	Hybrid bottom-up and top-down market sizing supported by primary interviews and official desk research.

Pediatric Neurosurgery XR Solutions Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Pediatric Neurosurgery XR Solutions Market by Segments

Pediatric Neurosurgery XR Solutions Market segmented by Component:

• Hardware
• Software
• Services
• Platforms

Pediatric Neurosurgery XR Solutions Market segmented by Application:

• Preoperative Planning
• Surgical Navigation
• Medical Training
• Patient Education

Pediatric Neurosurgery XR Solutions Market segmented by Technology:

• Virtual Reality
• Augmented Reality
• Mixed Reality
• Extended Reality

Pediatric Neurosurgery XR Solutions Market segmented by End User:

• Pediatric Hospitals
• Neurosurgery Centers
• Academic Medical Centers
• Specialty Clinics

Pediatric Neurosurgery XR Solutions Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• Stanford Medicine Children's Health. (n.d.). Surgical Theater Technology.
• Ruggiero, F., Cercenelli, L., Tarsitano, A., Emiliani, N., Stradiotti, S., Babini, M., Gardenghi, B., Lefosse, M., Marcelli, E., & Zucchelli, M. (2025, August 29). Augmented reality in pediatric craniofacial surgery: clinical experience. Journal of Neurosurgery: Pediatrics, 36(5), 657-663.
• USA Food and Drug Administration. (2026, June 16). Augmented Reality and Virtual Reality in Medical Devices.
• Brainlab. (n.d.). Mixed Reality Viewer for Neurosurgery: View brain anatomy at every angle.
• Surgical Theater. (n.d.). PlanXR™.
• ImmersiveTouch. (n.d.). Precision and speed redefined: revolutionize virtual surgical planning with ImmersiveView 5™.
• King's College Hospital NHS Foundation Trust. (2025, December 4). King’s paediatric neurosurgical oncology service receives Tessa Jowell Centre of Excellence accreditation.
• USA Food and Drug Administration. (2026, February 3). Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions.
• Imperial College Healthcare NHS Trust. (2025, February 28). UK and US neurosurgeons in mixed reality first.
• Avatar Medical. (2025, March 11). Avatar Medical Vision Receives CE Marking.
• Avatar Medical. (2026, June 25). University of Miami Health System to Deploy Avatar Medical and Barco’s Eonis Vision for Patient Consultations.
• Avatar Medical. (2026, April 28). Avatar Medical Receives FDA 510(k) Clearance for Avatar Medical Vision, the First Software Cleared for Use with Glasses-Free 3D Medical Displays.
• Federal Ministry of Health. (2025, December 19). Changes in the areas of health and long-term care in 2026.
• Holoeyes. (2026, April 22). 「Holoeyes MD」[Holoeyes MD medical image-processing software was certified under the Tokyo trial procurement program for fiscal 2026].
• Ministry of Health and Welfare. (2025, February 27). [Higher reimbursement for complex surgery and continued expansion of rare-disease coverage].
• SKIA. (n.d.). SKIA Neuro.
• Medivis. (2025, December 16). Medivis First to Receive FDA Clearance for Augmented Reality Navigation in Neurosurgery.
• Brainlab. (2025, September 18). Brainlab Announces FDA 510(k) Clearance and US Launch of Spine Mixed Reality Navigation.
• Holoeyes. (2026, January 27). Holoeyes MD[Holoeyes MD adds a new Library function].
• Novarad. (2025, May 6). Guided Spinal Navigation Landmark Surgery Opens the Door to Cost-Effective 3D Augmented Reality.
• Novarad. (n.d.). Increase accuracy with Novarad’s Augmented Reality Surgical Navigation Solutions.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• How large is the pediatric neurosurgery XR solutions market in 2026 and 2036?
• Which clinical pressures support investment in patient-specific pediatric neurosurgery XR workflows?
• Why is hardware estimated to hold 40.1% share of the component category in 2026?
• How does preoperative planning support multidisciplinary decision-making before complex pediatric procedures?
• Why is virtual reality positioned as the primary technology focus during 2026?
• How do country growth rates differ across the USA, UK, Germany, Japan, and South Korea?
• Which companies provide planning, navigation, communication, or education platforms for pediatric neurosurgery?
• What limits adoption across image registration, cybersecurity, service coverage, and clinical training?
• How should pediatric hospitals evaluate return on investment across repeated clinical workflows?